Multiplex Assay Kit for Endothelial protein C receptor (EPCR) ,etc. by FLIA (Flow Luminescence Immunoassay)

CD201; PROCR; CCCA ;CCD41; BA42O4.2; EPCR; Endothelial Protein C Receptor; Cell Cycle, Centrosome-Associated Protein; Activated Protein C Receptor

(Note: Up to 8-plex in one testing reaction)

Specificity

This assay has high sensitivity and excellent specificity for detection of Endothelial protein C receptor (EPCR) ,etc. by FLIA (Flow Luminescence Immunoassay).
No significant cross-reactivity or interference between Endothelial protein C receptor (EPCR) ,etc. by FLIA (Flow Luminescence Immunoassay) and analogues was observed.

Recovery

Matrices listed below were spiked with certain level of recombinant Endothelial protein C receptor (EPCR) ,etc. by FLIA (Flow Luminescence Immunoassay) and the recovery rates were calculated by comparing the measured value to the expected amount of Endothelial protein C receptor (EPCR) ,etc. by FLIA (Flow Luminescence Immunoassay) in samples.

Matrix Recovery range (%) Average(%)
serum(n=5) 86-101 92
EDTA plasma(n=5) 83-101 95
heparin plasma(n=5) 78-91 83

Precision

Intra-assay Precision (Precision within an assay): 3 samples with low, middle and high level Endothelial protein C receptor (EPCR) ,etc. by FLIA (Flow Luminescence Immunoassay) were tested 20 times on one plate, respectively.
Inter-assay Precision (Precision between assays): 3 samples with low, middle and high level Endothelial protein C receptor (EPCR) ,etc. by FLIA (Flow Luminescence Immunoassay) were tested on 3 different plates, 8 replicates in each plate.
CV(%) = SD/meanX100
Intra-Assay: CV<10%
Inter-Assay: CV<12%

Linearity

The linearity of the kit was assayed by testing samples spiked with appropriate concentration of Endothelial protein C receptor (EPCR) ,etc. by FLIA (Flow Luminescence Immunoassay) and their serial dilutions. The results were demonstrated by the percentage of calculated concentration to the expected.

Sample 1:2 1:4 1:8 1:16
serum(n=5) 95-102% 93-103% 88-102% 89-103%
EDTA plasma(n=5) 86-101% 89-104% 80-104% 89-104%
heparin plasma(n=5) 97-104% 91-105% 84-98% 79-96%

Stability

The stability of kit is determined by the loss rate of activity. The loss rate of this kit is less than 5% within the expiration date under appropriate storage condition.
To minimize extra influence on the performance, operation procedures and lab conditions, especially room temperature, air humidity, incubator temperature should be strictly controlled. It is also strongly suggested that the whole assay is performed by the same operator from the beginning to the end.

Reagents and materials provided

Reagents Quantity Reagents Quantity
96-well plate 1 Plate sealer for 96 wells 4
Pre-Mixed Standard 2 Standard Diluent 1×20mL
Pre-Mixed Magnetic beads (22#:EPCR) 1 Analysis buffer 1×20mL
Pre-Mixed Detection Reagent A 1×120μL Assay Diluent A 1×12mL
Detection Reagent B (PE-SA) 1×120μL Assay Diluent B 1×12mL
Sheath Fluid 1×10mL Wash Buffer (30 × concentrate) 1×20mL
Instruction manual 1

Assay procedure summary

1. Preparation of standards, reagents and samples before the experiment;
2. Add 100μL standard or sample to each well,
    add 10μL magnetic beads, and incubate 90min at 37°C on shaker;
3. Remove liquid on magnetic frame, add 100μL prepared Detection Reagent A. Incubate 60min at 37°C on shaker;
4. Wash plate on magnetic frame for three times;
5. Add 100μL prepared Detection Reagent B, and incubate 30 min at 37°C on shaker;
6. Wash plate on magnetic frame for three times;
7. Add 100μL sheath solution, swirl for 2 minutes, read on the machine.

GIVEAWAYS

INCREMENT SERVICES

Magazine Citations
ВЕСТНИК НОВЫХ МЕДИЦИНСКИХ ТЕХНОЛОГИЙ СОВЕРШЕНСТВОВАНИЕ ЛЕЧЕБНО-ДИАГНОСТИЧЕСКИХ МЕРОПРИЯТИЙ ПРИ ГРИППЕ ВО ВРЕМЯ БЕРЕМЕННОСТИ Bulletin: E2015-1
Experimental and Therapeutic Medicine Unfractionated heparin protects the protein C system against lipopolysaccharide‑induced damage in vivo and in vitro 10.3892/etm.2017.5236
Biomed Pharmacother Effects and mechanisms of PSS-loaded nanoparticles on coronary microcirculation dysfunction in streptozotocin-induced diabetic cardiomyopathy rats Pubmed: 31715373
BULLETIN OF EXPERIMENTAL BIOLOGY AND MEDICINE Effect of Nitinol on Metabolic and Coagulation Activity of Endothelial Cells Culture 34542754
Catalog No. Related products for research use of Rattus norvegicus (Rat) Organism species Applications (RESEARCH USE ONLY!)
RPA022Ra01 Recombinant Endothelial protein C receptor (EPCR) Positive Control; Immunogen; SDS-PAGE; WB.
PAA022Ra01 Polyclonal Antibody to Endothelial protein C receptor (EPCR) WB; IHC; ICC; IP.
LAA022Ra71 Biotin-Linked Polyclonal Antibody to Endothelial protein C receptor (EPCR) WB; IHC; ICC.
MAA022Ra21 Monoclonal Antibody to Endothelial protein C receptor (EPCR) WB; IHC; ICC; IP.
MEA022Ra Mini Samples ELISA Kit for Endothelial protein C receptor (EPCR) Enzyme-linked immunosorbent assay for Antigen Detection.
SEA022Ra ELISA Kit for Endothelial protein C receptor (EPCR) Enzyme-linked immunosorbent assay for Antigen Detection.
LMA022Ra Multiplex Assay Kit for Endothelial protein C receptor (EPCR) ,etc. by FLIA (Flow Luminescence Immunoassay) FLIA Kit for Antigen Detection.